Page 24 - Bharat Biotech

Recruited 8,000 volunteers already for phase 3 trials: Bharat Biotech head

The company says they are '200% transparent' about serious adverse events with regulator

World is watching India for 'safe' Covid vaccine, but are we ready?

Curbs may have to be maintained after vaccination: Ramanan Laxminarayan

Laxminarayan, in an interview with Geetika Srivastava, says that masks and small gatherings may stick around for a while

Review panel asks vaccine makers to submit more data to get authorisation

Experts ask Bharat Biotech for phase 3 data, Serum's UK approval status

Provide more safety data on Covid-19 vaccine: SEC to Serum, Bharat Biotech

The application submitted by the Pfizer was not discussed at the SEC meeting as the company has requested for more time for giving its presentation

Kiran Mazumdar-Shaw: Will take Covid vaccine; confident on safety, efficacy

Bharat Biotech, Serum Institute of India and Pfizer have applied to the Drugs Controller General of India seeking emergency use authorisation for their Covid-19 vaccine candidates

Coronavirus LIVE: Covid-19 situation in Delhi stabilising, says NITI Aayog

Coronavirus live updates: At 18,55,341, Maharashtra has the highest number of coronavirus cases, followed by Karnataka 894,004, Andhra Pradesh 872,288, Tamil Nadu 791,552, and Kerala 639,664

Top headlines: Call for emergency use of Covaxin; tax officers face heat

From Bharat Biotech applying for emergency use of Covaxin to super-rich buying luxury products online like never before, here are top headlines this morning

Bharat Biotech applies for emergency use authorisation for Covaxin

The company is conducting a 26,000 subjects phase 3 efficacy trial in India to determine the efficacy of its candidate

Vaccine efficacy based on 2 doses: Bharat Biotech after Vij tests positive

Covaxin is an indigenously developed Covid-19 vaccine undergoing a trial on over 26,000 people across 25 sites in India to evaluate the efficacy of the vaccine candidate

PM visits Bharat Biotech in Hyderabad to take stock of vaccine development

Modi visited drugmaker Zydus Cadila's plant near Ahmedabad earlier in the day.

Covid updates on vaccine, lockdown chances and PM's Serum institute visit

Russia's sovereign wealth fund and Indian pharmaceutical company Hetero have agreed to produce over 100 million doses per year of Russia's Covid vaccine Sputnik V, in India

PM Modi to visit Bharat Biotech's facility in Hyderabad on November 28

Prime Minister Narendra Modi is scheduled to visit vaccine maker Bharat Biotech's facility here on Saturday, the Telangana Chief Secretary Somesh Kumar said

Phase three trials of Bharat Biotech's covaxin commences in AIIMS

The trial will cover around 28,500 subjects aged 18 years and above

Covid vaccine: Bharat Biotech's Covaxin reach Ahmedabad for phase-3 trials

The Sola civil hospital is one of the 130 centres across the country where the third phase of clinical trials of Covaxin would be conducted

Serum Institute, Bharat Biotech gear up to export Covid-19 vaccine shots

Serum, Bharat Biotech in talks with countries, agencies to supply vaccines

No impact of adverse event on Covid-19 vaccine timelines: Bharat Biotech

The firm said subject was now safe. Though it was reported to the drug regulator within 24 hours, the event turned out to be unrelated to the vaccine.

Bharat Biotech's coronavirus vaccine may be launched in February

Moderna and AstraZeneca are close behind the largest US drugmaker and are likely to have early data on their vaccine candidates before the end of the year.

Govt to prioritise Covid-19 vaccine for front line health workers: Report

The national vaccine distribution plan is being formulated with the assumption that limited volumes of the inoculation will be available in the first few months of production, Paul said

Cadila scouts partners to ramp up Covid vaccine production by 50 to 70 mn

The Ahmedabad-based firm is looking to hire contract manufacturers for an additional 50 million to 70 million doses of its plasmid DNA vaccine